LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

Home・Akciju saraksts・Cartesian Therapeutics Inc

Cartesian Therapeutics Inc

Slēgts

7.87 4.93

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

7.79

Max

7.97

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+426.49% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2025. g. 12. nov.

Cartesian Therapeutics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 7. nov. 21:06 UTC

Galvenie tirgus virzītāji

JBS Down After Trump Calls for Probe into Meat-Packing Companies

2025. g. 7. nov. 22:36 UTC

Peļņas

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

2025. g. 7. nov. 22:22 UTC

Peļņas

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

2025. g. 7. nov. 22:03 UTC

Peļņas

Constellation Software 3Q Rev $2.95B >CSU.T

2025. g. 7. nov. 22:03 UTC

Peļņas

Constellation Software 3Q Net $210M >CSU.T

2025. g. 7. nov. 22:03 UTC

Peļņas

Constellation Software 3Q EPS $9.89 >CSU.T

2025. g. 7. nov. 21:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 7. nov. 21:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2025. g. 7. nov. 20:59 UTC

Peļņas

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

2025. g. 7. nov. 20:26 UTC

Tirgus saruna

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

2025. g. 7. nov. 20:22 UTC

Peļņas

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

2025. g. 7. nov. 20:04 UTC

Tirgus saruna

Oil Futures Close Choppy Week With Losses -- Market Talk

2025. g. 7. nov. 19:34 UTC

Tirgus saruna

Gold Posts Small Gain for Week -- Market Talk

2025. g. 7. nov. 19:31 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

2025. g. 7. nov. 19:17 UTC

Peļņas

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

2025. g. 7. nov. 19:09 UTC

Peļņas

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

2025. g. 7. nov. 19:08 UTC

Peļņas

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

2025. g. 7. nov. 18:31 UTC

Tirgus saruna

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

2025. g. 7. nov. 17:27 UTC

Tirgus saruna

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

2025. g. 7. nov. 17:20 UTC

Tirgus saruna

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

2025. g. 7. nov. 17:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 7. nov. 17:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 7. nov. 17:20 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2025. g. 7. nov. 17:17 UTC

Iegādes, apvienošanās, pārņemšana

Satair Expects to Complete Purchase in Early 2026

2025. g. 7. nov. 17:17 UTC

Iegādes, apvienošanās, pārņemšana

Satair: Deal Includes Unical's and ecube's Seven Operational Sites and Offices, With Combined 2024 Rev of $298M and Headcount of 413

2025. g. 7. nov. 17:15 UTC

Iegādes, apvienošanās, pārņemšana

Airbus Unit Satair to Buy Unical Aviation From Platinum Equity

2025. g. 7. nov. 17:09 UTC

Tirgus saruna

PENN Is Falling Further Behind Competitors -- Market Talk

2025. g. 7. nov. 16:49 UTC

Tirgus saruna

Losing ESPN Partnership Will Hurt PENN -- Market Talk

2025. g. 7. nov. 16:24 UTC

Tirgus saruna

OPEC+'s Output Hike Pause Comes Amid Excess Supply, Lower Spare Capacity -- Market Talk

2025. g. 7. nov. 16:17 UTC

Tirgus saruna

Oil Market Faces Oversupply But "Glut" Might Be Overblown -- Market Talk

Salīdzinājums

Cenas izmaiņa

Cartesian Therapeutics Inc Prognoze

Cenas mērķis

By TipRanks

426.49% augšup

Prognoze 12 mēnešiem

Vidējais 39.75 USD 426.49%

Augstākais 40 USD

Zemākais 39 USD

Pamatojoties uz 5 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Cartesian Therapeutics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

5 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 5 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Cartesian Therapeutics Inc — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Citi krājumi no sektora

LLY

Eli Lilly and Co.

922.39

↓-1.51%

JNJ

Johnson and Johnson

186.29

↓-0.03%

UNH

UnitedHealth Group Inc

324.11

↑ +0.82%

NVS

Novartis AG

126.28

↓-0.09%

ABT

Abbott Laboratories

126.19

↑ +1.02%

Cartesian Therapeutics Inc

Pārskats

Akcijas cenas izmaiņa

Rekomendācijas

Dividendes

Cartesian Therapeutics Inc Grafiks

Saistītās ziņas

Salīdzinājums

Cartesian Therapeutics Inc Prognoze

Cenas mērķis

Vērtējuma vienprātība

Finanšu rādītāji

Citi krājumi no sektora